Trends in the prescribing of psychotropic medications to preschoolers

JAMA

Volumn 283, Issue 8, 2000, Pages 1025-1030

  Zito, Julie Magno ^a,b,e   Safer, Daniel J ^c   DosReis, Susan ^a   Gardner, James F ^a   Boles, Myde ^d   Lynch, Frances ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CENTER FOR HEALTH RESEARCH   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT; CLONIDINE; METHYLPHENIDATE; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

AFFECTIVE NEUROSIS; AMBULATORY CARE; ARTICLE; BEHAVIOR DISORDER; DEMOGRAPHY; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; PRESCHOOL CHILD; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SOCIAL STATUS;

EID: 0034704577     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.8.1025     Document Type: Article

References (29)

1. Safer DJ, Zito JM, Fine EM. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics. 1996;98(6 pt 1):1084-1088.
2. Zito JM, dosReis S, Safer DJ, Gardner J. Trends in psychotropic prescriptions for youths with Medicaid insurance from a midwestern state: 1987-1995. Paper presented at: New Clinical Drug Evaluation Unit Meeting; June 1998; Boca Raton, Fla.
3. Greenhill LL. The use of psychotropic medication in preschoolers: indications, safety, and efficacy. Can J Psychiatry. 1998;43:576-581.
4. Minde K. The use of psychotropic medication in preschoolers: some recent developments. Can J Psychiatry. 1998;43:571-575.
5. Rappley MD, Gardiner JC, Mullan PB, Wang J, Alvarez FJ. Psychotropic medications in children ages 1 to 3 with ADHD. Paper presented at: Pediatric Academic Societies Meeting (Joint Specialties and Themes: Behavioral Pediatrics); May 4, 1998; New Orleans, La.
6. Pathiyal A, Miwa LJ, Sverdiov LS, Gardner E, Jones JK. Patterns of methylphenidate use. Paper presented at: American Society for Clinical Pharmacology and Therapeutics; March 31, 1998; New Orleans, La.
7. Vitiello B, Jensen PS. Medication development and testing in children and adolescents: current problems, future directions. Arch Gen Psychiatry. 1997; 54:871-876.
8. Grinfeld MJ, Psychoactive medications and kids: new initiatives launched. Psychiatric Times. 1998;15:69.
9. Zito JM, Safer DJ, Riddle MA, Johnson RE, Speedie SM, Fox M. Prevalence variations in psychotropic treatment of children. J Child Adolesc Psychopharmacol. 1998;8:99-105.
10. Jensen PS, Vitiello B, Leonard H, Laughren TP. Child and adolescent psychopharmacology: expanding the research base. Psychopharmacol Bull. 1994; 30:3-8.
11. Firestone P, Musten LM, Pisterman S, Mercer J, Bennett S. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study. J Child Adolesc Psychopharmacol. 1998;8:13-25.
12. Valentine J, Zubrick S, Sly P. National trends in the use of stimulant medication for attention deficit hyperactivity disorder. J Paediatr Child Health. 1996; 32:223-227.
13. Safer DJ, Zito JM. Pharmacoepidemiology of methylphenidate and other stimulants for the treatment of ADHD. In: Greenhill LL, Osman BB, eds. Ritalin: Theory and Practice. 2nd ed. Larchmont, NY: MA Liebert Publishers; 2000:7-26.
14. Davilla RR, Williams ML, MacDonald JT. Clarification of policy to address the needs of children with attention deficit hyperactivity disorders within general and/or special education. Memorandum from: US Dept of Education. Washington, DC: US Dept of Education, Office of Special Education; September 16, 1991.
15. Cantwell DP, Swanson J, Connor DF. Case study: adverse response to clonidine. J Am Acad Child Adolesc Psychiatry. 1997;36:539-544.
16. Swanson JM, Flockhart DA, Udrea D, Cantwell DP, Connor DF, Williams L. Clonidine in the treatment of ADHD: questions about safety and efficacy [letter]. J Child Adolesc Psychopharmacol. 1995;5: 301-304.
17. Prince JB, Wilens TE, Biederman J, Spencer TJ, Wozniak JR. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. J Am Acad Child Adolesc Psychiatry. 1996;35:599-605.
18. Ahmann PA, Waltonen SJ, Olson KA, Theye FW, Van Erem AJ, LaPlant RJ. Placebo-controlled evaluation of Ritalin side effects. Pediatrics, 1993;91:1101-1106.
19. Erickson SJ, Duncan A. Clonidine poisoning - an emerging problem: epidemiology, clinical features, management and preventive strategies. J Paediatr Child Health. 1998;34:280-282.
20. Kappagoda C, Schell DN, Hanson RM, Hutchins P. Clonidine overdose in childhood: implications of increased prescribing. J Paediatr Child Health. 1998; 34:508-512.
21. Popper CW. Combining methylphenidate and clonidine: pharmacologic questions and news reports about sudden death. J Child Adolesc Psychopharmacol. 1995;5:157-166.
22. Wilens TE, Spencer TJ, Swanson JM, Connor DF, Cantwell D. Combining methylphenidate and clonidine: a clinically sound medication option vs. ill-advised. J Am Acad Child Adolesc Psychiatry. 1999; 38:614-619.
23. Pincus HA, Tanielian TL, Marcus SC, et al. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA. 1998;279:526-531.
24. Foxman B, Valdez RB, Brook RH. Childhood enuresis: prevalence, perceived impact, and prescribed treatments. Pediatrics. 1986;77:482-487.
25. Geller B, Reising D, Leonard HL, Riddle MA, Walsh BT. Critical review of tricyclic antidepressant use in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1999;38:513-516.
26. Traversa G, Spila-Alegiani S, Arpino C, Ferrara M. Prescription of neuroleptics for children and adults in Italy. J Child Adolesc Psychopharmacol. 1998;8:175-180.
27. Perrin JM, Kuhlthau K, McLaughlin TJ, Ettner SL, Gortmaker SL. Changing patterns of conditions among children receiving Supplemental Security Income disability benefits. Arch Pediatr Adolesc Med. 1999;153: 80-84.
28. Hoagwood K, Jensen PS, Petti T, Burns BJ. Outcomes of mental health care for children and adolescents, I: a comprehensive conceptual model. J Am Acad Child Adolesc Psychiatry. 1996;35:1055-1063.
29. Vitiello B. Pediatric psychopharmacology and the interaction between drugs and the developing brain. Can J Psychiatry. 1998;43:582-584.